Listen to an audio podcast of the November 28, 2023, FDA Drug Safety Communication, FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan).
Similar Posts

Building a Loyal Blog Audience: Strategies for Engagement and Growth
Introduction Growing a dedicated and engaged audience is a critical aspect of successful blogging. This post explores effective strategies to build and maintain a loyal readership for your blog. 1. Know Your Audience Understanding who your readers are is fundamental. Tailor your content to their interests, needs, and preferences. Use analytics tools to gain insights…
FDA Drug Safety Podcasts
FDA Drug Safety Podcasts are produced by FDA’s Center for Drug Evaluation and Research (CDER)
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
August Egg Company Recalls Shell Eggs Because of Possible Health Risk
August Egg Company of Hilmar, CA is recalling 1,700,000 dozen brown cage free and brown certified organic eggs, because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and other
Infusion Pump Correction: Baxter Updates Instructions for Use for Novum IQ Large Volume Pump due to Potential for Underinfusion
Infusion Pump Correction: Baxter Issues Correction for Novum IQ Large Volume Pump due to Potential for Underinfusion
Symrise, S. de R.L de C.V. – 9/21/2018
Symrise, S. de R.L de C.V. – 9/21/2018. Country: Mexico. Record Type: 483